Noven Announces 2004 Earnings Release Date

-- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the scheduled release date of its 2004 financial results.

On March 15, before the market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter and year ended December 31, 2004. At 11:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same website. A taped replay of the call will be available beginning in the afternoon of March 15 through March 17 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the account #286 and the conference ID #140929.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Alina Canales
Investor Relations Coordinator
305-253-1916